- ISIN
- US74265M2052
- CUSIP
- 74265M205
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Aug 18, 1995
Highlights
- Market Cap
- $210.57M
- Enterprise Value
- $224.10M
- EPS (TTM)
- $3.62
- PE Ratio
- 17.79
- PEG Ratio
- 0.21
- Total Revenue (TTM)
- $74.64M
- Gross Profit (TTM)
- $20.73M
- EBITDA (TTM)
- $16.82M
- Year Range
- $23.47 - $68.99
- ROA (TTM)
- 16.01%
- ROE (TTM)
- 26.55%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PDEX Performance Chart
Pro-Dex, Inc. (PDEX) is up 67.4% since the beginning of the year. At $64 per share, PDEX is trading 6.7% below its 52-week high of $69. Investors who bought $1,000 worth of PDEX shares 5 years ago would now be looking at an investment worth $2,194.
Loading charts...
Returns By Period
Pro-Dex, Inc. (PDEX) has returned 67.36% so far this year and 58.86% over the past 12 months. Looking at the last ten years, PDEX has achieved an annualized return of 28.94%, outperforming the S&P 500 Index benchmark, which averaged 13.88% per year.
Pro-Dex, Inc.
- 1D
- 0.05%
- 1M
- 1.39%
- YTD
- 67.36%
- 6M
- 50.89%
- 1Y
- 58.86%
- 3Y*
- 49.82%
- 5Y*
- 17.02%
- 10Y*
- 28.94%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
PDEX Monthly Returns History
Based on dividend-adjusted daily data since Aug 18, 1995, PDEX's average daily return is +0.13%, while the average monthly return is +1.74%. At this rate, an investment would double in approximately 3.3 years.
Historically, 52% of months were positive and 48% were negative. The best month was Nov 2018 with a return of +65.9%, while the worst month was Apr 2001 at -41.1%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.
On a daily basis, PDEX closed higher 42% of trading days. The best single day was Sep 18, 2002 with a return of +71.1%, while the worst single day was Oct 11, 2002 at -40.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.95% | 12.95% | 10.86% | 2.08% | 29.18% | -0.57% | 67.36% | ||||||
| 2025 | -18.78% | -8.56% | 42.80% | 32.47% | -39.03% | 8.98% | 14.69% | -6.33% | -27.79% | 7.06% | 0.55% | 5.60% | -17.69% |
| 2024 | 22.83% | -20.54% | 2.92% | 5.11% | 6.54% | -0.36% | 2.95% | 15.38% | 27.95% | 3.92% | 64.41% | -8.33% | 166.84% |
| 2023 | 8.36% | -10.21% | 6.08% | -3.11% | 19.50% | 0.53% | -5.76% | -5.50% | -7.70% | 8.28% | -4.94% | 8.42% | 10.19% |
| 2022 | 5.77% | -24.40% | -10.94% | -8.65% | 5.89% | -0.25% | 0.38% | 19.93% | -7.71% | 9.42% | -9.18% | -9.71% | -31.50% |
| 2021 | -0.03% | -20.38% | 9.33% | 5.83% | 19.85% | -10.59% | 0.39% | -17.86% | 1.87% | -5.45% | -7.09% | 2.93% | -25.06% |
Benchmark Metrics
Pro-Dex, Inc. has an annualized alpha of 33.34%, beta of 0.49, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since August 18, 1995.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (39.96%) than losses (31.22%) - typical of diversified or defensive assets.
- Beta of 0.49 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 33.34%
- Beta
- 0.49
- R²
- 0.02
- Upside Capture
- 39.96%
- Downside Capture
- 31.22%
Return for Risk
Risk / Return Rank
PDEX ranks 67 for risk / return — better than 67% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Pro-Dex, Inc. (PDEX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PDEX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.11 | ||
| Sortino ratioReturn per unit of downside risk | -1.28 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.37 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 1.07 | 2.78 | -1.72 |
| Martin ratioReturn relative to average drawdown | 2.46 | 12.44 | -9.98 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Pro-Dex, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Pro-Dex, Inc. was 95.50%, occurring on Mar 3, 2009. Recovery took 2753 trading sessions.
The current Pro-Dex, Inc. drawdown is 6.67%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Financial crisis2007–2009 | -95.50%Mar 2009 | 12y 9mo | 10y 11mo | 23y 8moMay 1996 - Feb 2020 |
Bear market2022 | -69.11%May 2022 | 1y 4mo | 2y 6mo | 3y 10moDec 2020 - Nov 2024 |
2025 bear market2025 | -65.36%Oct 2025 | 5mo 20d | — | 1y 1moApr 2025 - now |
2025 selloff2025 | -44.62%Feb 2025 | 1mo 15d | 1mo 17d | 3mo 2dJan 2025 - Apr 2025 |
COVID crash2020 | -36.90%Mar 2020 | 15d | 4mo 23d | 5mo 8dMar 2020 - Aug 2020 |
Drawdown Indicators
| PDEX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.50% | -56.78% | -38.72% |
Max Drawdown (1Y)Largest decline over 1 year | -55.32% | -9.10% | -46.22% |
Max Drawdown (3Y)Largest decline over 3 years | -65.36% | -18.90% | -46.46% |
Max Drawdown (5Y)Largest decline over 5 years | -65.36% | -25.43% | -39.93% |
Max Drawdown (10Y)Largest decline over 10 years | -69.11% | -33.92% | -35.19% |
Current DrawdownCurrent decline from peak | -6.67% | -1.80% | -4.87% |
Average DrawdownAverage peak-to-trough decline | -63.65% | -10.71% | -52.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.96% | 2.03% | +21.93% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Pro-Dex, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Pro-Dex, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PDEX, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, PDEX has a P/E ratio of 17.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for PDEX compared to other companies in the Medical Instruments & Supplies industry. PDEX currently has a PEG ratio of 0.2. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PDEX relative to other companies in the Medical Instruments & Supplies industry. Currently, PDEX has a P/S ratio of 2.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PDEX in comparison with other companies in the Medical Instruments & Supplies industry. Currently, PDEX has a P/B value of 4.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PDEX
Add Pro-Dex, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PDEX